Decheng Capital LLC Legend Biotech Corp Transaction History
Decheng Capital LLC
- $466 Billion
- Q4 2024
A detailed history of Decheng Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Decheng Capital LLC holds 153,558 shares of LEGN stock, worth $5.85 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
153,558
Previous 108,558
41.45%
Holding current value
$5.85 Million
Previous $5.29 Billion
5.54%
% of portfolio
1.07%
Previous 1.25%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
233Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$286 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$259 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$228 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$218 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$218 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.37B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...